Market Cap 54.24M
Revenue (ttm) 117.27M
Net Income (ttm) -16.45M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -14.03%
Debt to Equity Ratio 0.80
Volume 103,400
Avg Vol 90,166
Day's Range N/A - N/A
Shares Out 139.07M
Stochastic %K 84%
Beta -0.03
Analysts Strong Sell
Price Target $1.75

Latest News on XTNT

Xtant Medical Reports Third Quarter 2024 Financial Results

Nov 12, 2024, 4:05 PM EST - 5 months ago

Xtant Medical Reports Third Quarter 2024 Financial Results


Xtant Medical Announces $5.0 Million Private Placement

Aug 8, 2024, 7:20 AM EDT - 9 months ago

Xtant Medical Announces $5.0 Million Private Placement


Xtant Medical Reports Second Quarter 2024 Revenue Growth of 48%

Aug 8, 2024, 7:05 AM EDT - 9 months ago

Xtant Medical Reports Second Quarter 2024 Revenue Growth of 48%


Xtant Medical Announces Second Quarter Revenue Growth of 32%

Aug 1, 2023, 7:00 AM EDT - 1 year ago

Xtant Medical Announces Second Quarter Revenue Growth of 32%


Xtant Medical Announces $15 Million Private Placement

Jul 3, 2023, 7:27 AM EDT - 1 year ago

Xtant Medical Announces $15 Million Private Placement


Xtant Medical Announces Third Quarter 2022 Financial Results

Nov 3, 2022, 7:00 AM EDT - 2 years ago

Xtant Medical Announces Third Quarter 2022 Financial Results


Xtant Medical Announces Second Quarter 2022 Financial Results

Aug 4, 2022, 7:00 AM EDT - 2 years ago

Xtant Medical Announces Second Quarter 2022 Financial Results